EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma

Yang Zhao, JiaYing Lai, RunBin Liang, MinKe He, Ming Shi

Journal of Interventional Medicine · 2019

DOI: 10.1016/j.jimed.2019.07.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Interventional Medicine, 2019. Verfasst von Yang Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Science and Technology Major Project of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Barcelona clinic liver cancer stage CHepatic arterial infusion chemotherapyHepatocellular carcinomaOxaliplatinSorafenib

Autor:innen und Institutionen

  • Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • HuiDong Senior Middle School, Huidong, Huizhou, China.

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • National Science and Technology Major Project of China

Zitieren

APA

Zhao, Y., Lai, J., Liang, R., He, M., & Shi, M. (2019). Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma. Journal of Interventional Medicine. https://doi.org/10.1016/j.jimed.2019.07.005

Vancouver

Zhao Y, Lai J, Liang R, He M, Shi M. Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma. Journal of Interventional Medicine. 2019. doi:10.1016/j.jimed.2019.07.005

BibTeX
@article{Zhao2019,
  author = {Zhao, Yang and Lai, JiaYing and Liang, RunBin and He, MinKe and Shi, Ming},
  title = {Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma},
  journal = {Journal of Interventional Medicine},
  year = {2019},
  doi = {10.1016/j.jimed.2019.07.005}
}
Kostenlos starten →